Perspectives by the Leerink Center for Pharmacoeconomics

EXPLORE

Society & Culture

Health & Fitness

© 2024 PodJoint

Loading...

0:00 / 0:00

Sign in

or

Don't have an account?

Sign up

Forgot password

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/ee/36/b7/ee36b702-2a97-c047-0f32-c339c6acc027/mza_11381342764586184688.jpg/600x600bb.jpg

Perspectives by the Leerink Center for Pharmacoeconomics

The Leerink Center for Pharmacoeconomics

11 episodes

6 days ago

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech, to discuss the impact of the Inflation Reduction...

Show more...

All content for Perspectives by the Leerink Center for Pharmacoeconomics is the property of The Leerink Center for Pharmacoeconomics and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech, to discuss the impact of the Inflation Reduction...

Show more...

Episodes (11/11)

Perspectives by the Leerink Center for Pharmacoeconomics

Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech

3 weeks ago

Perspectives by the Leerink Center for Pharmacoeconomics

The IP Policy Institute’s Joshua Kresh and Emily Michiko Morris

1 month ago

Perspectives by the Leerink Center for Pharmacoeconomics

Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA

2 months ago

Perspectives by the Leerink Center for Pharmacoeconomics

Head of Patient Engagement and Patient-Centered Innovation, Raven, RA Capital's healthcare incubator, Gunnar Esiason, MBA, MPH

3 months ago

Perspectives by the Leerink Center for Pharmacoeconomics

Vice Chair of Research and Associate Professor, University of Utah, Joey Mattingly, PharmD, MBA, PhD

4 months ago

Perspectives by the Leerink Center for Pharmacoeconomics

Chief Science Officer, National Pharmaceutical Council, Jon Campbell, PhD

5 months ago

33 minutes

Perspectives by the Leerink Center for Pharmacoeconomics

Head of U.S. Public Affairs and Patient Advocacy, Oncology with Sanofi, Elizabeth Franklin, PhD, MSW

6 months ago

34 minutes

Perspectives by the Leerink Center for Pharmacoeconomics

Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen

7 months ago

25 minutes

Perspectives by the Leerink Center for Pharmacoeconomics

Managing Director of Pharmagellan and Professor of the Practice at Tufts University, Frank S. David, MD, PhD

8 months ago

38 minutes

Perspectives by the Leerink Center for Pharmacoeconomics

Author of the Cost Curve & the Principal and Founder of Reid Strategic, Brian Reid

9 months ago

32 minutes

Perspectives by the Leerink Center for Pharmacoeconomics

Welcome to Perspectives by the Leerink Center for Pharmacoeconomics

10 months ago

Perspectives by the Leerink Center for Pharmacoeconomics

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech, to discuss the impact of the Inflation Reduction...